Advanced search
Publication Cover
Aging Health Volume 9, 2013 - Issue 2
Journal homepage
155
Views
0
CrossRef citations to date
0
Altmetric
Review

Rheumatoid Arthritis in the Elderly: Recent Advances in Understanding the Pathogenesis, Risk Factors, Comorbidities and Risk–Benefit of Treatments

Thasia Woodworth1 David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA90095, USAView further author information
,
Veena Ranganath1 David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA90095, USAView further author information
&
Daniel E Furst1 David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA90095, USA. [email protected].Correspondence[email protected]
View further author information
Pages 167-178 | Published online: 04 Apr 2013

References

  • Scott DL , WolfeF, HuinzingaT. Rheumatoid arthritis. Lancet376, 1094–1108(2010).
  • Helmick CG , FelsonDT, LawrenceRCet al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 58(1), 15–25(2008).
  • Rasch EK , HirschR, Paulose-RamR, HochbergM. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. Arthritis Rheum.48(4), 917–926(2003).
  • Humphreys JH , VerstappenSMM, HyrichKL, ChippingJR, MarshallT, SymmonsDPM. The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR Classification Criteria and the 1987 ACR Classification Criteria. Results from the Norfolk Arthritis Register. Ann. Rheum. Dis. doi:10.1136/annrheumdis-2012-201960 (2012) (Epub ahead of print).
  • Myasoedova E , CrowsonCS, KremersHM, TherneauTM, GabrielSE. Is the incidence of rheumatoid arthritis rising? Results from Olmstead County 1955–2007. Arthritis Rheum.62(6), 1576–1582(2010).
  • Cho SK , SungYK, ChoiCBet al. Do patients with elderly-onset rheumatoid arthritis have severe functional disability? Semin. Arthritis Rheum. 42(1), 23–31(2012).
  • Neovius M , SimardJF, Askling J; ARTIS Study Group. Nationwide prevalence of rheumatoid arthritis and penetration of disease modifying drugs in Sweden. Ann. Rheum. Dis.70(4), 824–829(2010).
  • Tutuncu Z , ReedG, KremerJ, KavanaughA. Do patients with older-onset rheumatoid arthritis receive less aggressive treatment? Ann. Rheum. Dis.65, 1226–1229(2006).
  • Gullick NJ , ScottDL. Co-morbidities in established rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol.25(4), 469–483(2011).
  • Gabriel SG , MichaudK. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res. Ther.11(3), 229 (2009).
  • Ranganath VE , MaranianP, ElashoffDAet al. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis. Rheumatology (2013) (In Press).
  • Scott IC , SteerIS, LewisCM. Precipitating and perpetuating factors of rheumatoid arthritis immunopathology – linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis. Best Pract. Res. Clin. Rheumatol.25, 447–468(2011).
  • Wu H , KhannaD, ParkGet al. Interaction between RANKL and HLA–DRB1 genotypes may contribute to younger age at onset of seropositive rheumatoid arthritis in an inception cohort. Arthritis Rheum. 50(10), 3093–3103(2004).
  • Hohensinner PJ , GoronzyJJ, WeyandCM. Telomere dysfunction, autoimmunity and aging. Aging Dis.2(6), 524–537(2011).
  • Chen DY , HsiehTY, ChenYM, HsiehCW, LanJL, LinFJ. Proinflammatory cytokine profile of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease. Gerontology55, 250–258(2009).
  • Deane KD , O‘DonnellCI, HueberWet al. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner. Arthritis Rheum. 62(11), 3161–3172(2010).
  • Kokkonen H , SöderströmI, RocklovJ, HallmansG, LejonK, Rantapää Dahlqvist S. Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum.62(2), 383–391(2010).
  • Deane KD . Learning about the natural history of rheumatoid arthritis development through prospective study of subjects at high risk of rheumatoid arthritis-related autoimmunity. Arthritis Rheum.64(6), 1708–1712(2012).
  • Nielsen SF , BojesenSE, SchnohrP, NordestgaardG. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ345, e5244 (2012).
  • Lahiri M , MorganC, SymmonsDP, BruceIN. Modifiable risk factors for RA: prevent, better than cure? Rheumatology51, 499–512(2012).
  • Liao KP , AlfredssonL, KarlsonEW. Environmental influences on risk for rheumatoid arthritis. Curr. Opin. Rheumatol.21(3), 279–283(2009).
  • Detert J , PichonN, BurmesterGR, ButtgereitF. The association between rheumatoid arthritis and periodontal disease. Arthritis Res. Ther.12, 218 (2010).
  • Mikuls TR , ThieleGM, DeaneKDet al. Porphyomonas gingivalis and disease-related autoantibodies in indivduals at increased risk of rheumatoid arthritis. Arthritis Rheum. 64(11), 3522–3530(2012).
  • Scher JU , UbedaC, EquindaMet al. Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis. Arthritis Rheum. 64(10), 3083–3094(2012).
  • Savioli C , RibeiroACM, FabriGMCet al. Persistent periodontal disease hampers anti-tumor necrosis treatment response in rheumatoid arthritis. J. Clin. Rheumatol. 18(4), 180–184(2012).
  • Smit MD , WestraJ, VissinkA, Doornbos-van der Meer B, Brouwer E, van Winkelhoff AJ. Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study. Arthritis Res. Ther.14(5), R222 (2012).
  • Pikwer M , BergströmU, NilssonJA, JacobssonL, TuressonC. Early menopause is an independent predictor of rheumatoid arthritis. Ann. Rheum. Dis.71(3), 378–381(2012).
  • Pikwer M , NilssonJA, BergstromU, JacobssonLTH, TuressonC. Early menopause and severity of rheumatoid arthritis in women over 45 years of age. Arthritis Res. Ther.14, R190 (2012).
  • McCarey DW , McInnesIB, MadhokRet al. Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomized placebo-controlled trial. Lancet 363, 2015–2021(2009).
  • Jick SS , ChoiH, LiL, McInnesIB, SattarN, Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis. Ann. Rheum. Dis.68, 546–551(2009).
  • De Jong HJ , KlungelOH, van Dijk L et al. Use of statins is associated with an increased risk of rheumatoid arthritis. Ann. Rheum. Dis.71, 648–654(2012).
  • Villa-Blanco JI , Calvo-AlénJ. Elderly onset rheumatoid arthritis: differential diagnosis and choice of first-line and subsequent therapy. Drugs Aging26(9), 739–750(2009).
  • El-Labban AS , Abo Omar HAS, El-Shereif FA, El-Mansoury TM. Pattern of Young and Old Onset Rhuematoid Arthritis (YORA and EORA Among a Group of Egyptian Patients with Rheumatoid Arthritis. Clin. Med. Insights Arthritis Musculoskelet. Disord.3, 25–31(2010).
  • Pease CT , BhaktaBB, DevlinJ, EmeryP. Does the age of onset of rheumatoid arthritis influence phenotype? A prospective study of outcome and prognostic factors. Rheumatology (Oxford)38(3), 228–234(1997).
  • Deal CL , MeenanRF, GoldenbergDLet al. The clinical feature of elderly-onset rheumatoid arthritis, a comparison with younger-onset disease of similar duration. Arthritis Rheum. 28(9), 987–994(1985).
  • Aletaha D , NeogiT, SilmanAJet al. 2010 Rheumatoid Arthritis Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62(9), 2569–2581(2010).
  • Tamas M -M, Felea I. How much difference does the age at onset make in early arthritis patients? Comparison between the ACR 1987 and the ACR/EULAR 2010 Classification Criteria for rheumatoid arthritis at the time of diagnosis. Rheumatol. Int. doi:10.1007/s00296-012-2515-2510 (2012) (Epub ahead of print).
  • Zeidler H . The need to better classify and diagnose early and very early rheumatoid arthritis. J. Rheumatol.39(2), 212–217(2012).
  • Bhakta BB , PeaseCT. Late-onset rheumatoid arthritis: is pitting edema of the hands at onset a good prognostic indicator? Br. J. Rheumatol.36(2), 214–219(1997).
  • Kimura M , TokudaY, OshiawaHet al. Clinical characteristics of patients with remitting seronegative symmetrical synovitis with pitting edema compared to patients with pure polymyalgia rheumatica. J. Rheumatol. 39, 148–153(2012).
  • Pease CT , HaugebergG, MontagueBet al. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology 48(2), 123–127(2008).
  • Ceccato F , RoveranoS, BarrionuevoA, RilloO. The role of anticyclic citrullinated peptide antibodies in the differential diagnosis of elderly-onset rheumatoid arthritis and polymyalgia rheumatica. Clin. Rheumatol.25, 854–857(2006).
  • Dasgupta B , CimminoMA, KremersHMet al. 2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 64(4), 943–954(2012).
  • Tutuncu Z , KavanaughA. Rheumatic disease in the elderly: rheumatoid arthritis. Rheum. Dis. Clinics North Am.33(1), 57–70(2007).
  • Radovits BJ , KievitW, FransenJet al. Influence of age on the outcome of anti-tumour necrosis factor alpha therapy in rheumatoid arthritis. Ann. Rheum. Dis. 68(9), 1470–1473(2009).
  • van Assen S , Agmon-LevinN, ElkyamOet al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann. Rheum. Dis. 70, 414–422(2010).
  • Dao K , CushJJ. A vaccination primer for rheumatologists. Drug Safety Quarterly4(1), 1–2(2012).
  • Zhang J , XieF, DelzellEet al. Association between vaccination for herpes zoster and risk of herpes zoster infection among patients with selected autoimmune diseases. JAMA 308(1), 43–49(2012).
  • Crowson CS , GabrielSE. Towards improving cardiovascular risk management in rheumatoid arthritis: the need for accurate risk assessment. Ann. Rheum. Dis.70, 719–721(2011).
  • Solomon DH , KremerJ, CurtisJRet al. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity. Ann. Rheum. Dis. 69, 1920–1925(2010).
  • Van Halm VP , PetersMJL, VoskuylAEet al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann. Rheum. Dis. 68, 1395–1400(2009).
  • Lindhardsen J , AhlehoffO, GislasonGHet al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann. Rheum. Dis. 70, 929–937(2011).
  • Semb AG , KvienTK, DeMiccoDAet al. Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. Arthritis Rheum. 64(9), 2836–2846(2012).
  • De Vera MA , ChoiH, AbrahamowiczM, KopecJ, LacailleD. Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study. Arthritis Care Res.64(6), 809–816(2012).
  • Haque UJ , BathonJ, GilesJT. Association of Vitamin D with cardiometabolic risk factors in rheumatoid arthritis. Arthritis Care Res.64(10), 1497–1504(2012).
  • Baker JF , MehtaNN, BakerDGet al. Vitamin D, metabolic dyslipidemia, and metabolic syndrome in rheumatoid arthritis. Am. J. Med. 125(10), 1036.e9–1036.e15 (2012).
  • Kim SY , SchneeweisS, LiuJet al. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res. Ther. 12, R154 (2010).
  • Schett G , SaagKG, BijlsmaJWJ. From bone biology to clinical outcome: state of the art and future perpectives. Ann. Rheum. Dis.69, 1415–1419(2010).
  • Ravi B , EscottB, ShahPSet al. A systematic review and meta-analysis comparing the complications of total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 64(12), 3839–3849(2012).
  • Teitelbaum SL , SetonMP, SaagKG. Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? Arthritis Rheum.63(2), 325–328(2011).
  • Karras D , StoykovI, LemsWFet al. Effectiveness of teriparatide in post-menopausal women with osteoporosis and glucocorticoid use: 3 year results from the EFOS study. J. Rheumatol. 39(3), 600–609(2012).
  • Shin YS , KatzP, WallhagenM, JulianL. Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res.64(8), 1144–1150(2012).
  • Rattery G , HeJ, PearceRet al. Disease activity and cognition in rheumatoid arthritis: an open label pilot study. Arthritis Res. Ther. 14, R263 (2012).
  • Smitten AL , SimonTA, HochbergMC, SuissaS. A meta-analysis of malignancy in adult patients with rheumatoid arthritis. Arthritis Res. Ther.10(2), R45 (2008).
  • Smolen JS , AletahaD, BijlsmaJWJet al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631–637(2010).
  • Singh JA , FurstDE, AseemBet al. 2012 Update of the 2008 American College of Rheumatology recommendations for use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res. 64(5), 625–631(2012).
  • Bukhari M , LuntM, BartonA, BunnD, SilmanA, SymmonsD. Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann. Rheum. Dis.66, 389–393(2007).
  • Comacho EM , VerstappenSMM, LuntM, BunnDK, SymmonsDPM. Influence of age and sex on functional outcome over time in a cohort of patients with recent onset inflammatory polyarthritis: results from the Norfolk Register. Arthritis Care Res.63(12), 1745–1752(2011).
  • Avina-Zubieta JA , ChoiHK, SadatsafaviMet al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta analysis of observational studies. Arthritis Care Res. 59(12), 1690–1697(2008).
  • Zink A , StrangfeldA, SchneiderMet al. Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trials. Arthritis Rheum. 54(11), 3399–3407(2006).
  • Singh J , CameronDR. Summary of AHRQ‘s comparative effectiveness review of drug therapy for rheumatoid arthritis (RA) in adults. J. Manag. Care Pharm.18(4 Suppl. C), S1–S18 (2012).
  • Sogol SS , RanganathVE, FurstDE. Disease-modifying antirheumatic drug use in older rheumatoid arthritis patients in geriatric rheumatology: a comprehensive approach. In: Geriatric Rheumatology. Nakasato Y, Yung RL (Eds). Springer, NY, USA, 157–172(2011).
  • Widdiefield J , BernatskyS, PatersonJMet al. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res. (Hoboken) doi:10.002/acr.21812 (2012) (Epub ahead of print).
  • Dixon WG , AbrahamowiczM, BeauchampMEet al. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann. Rheum. Dis. 71, 1128–1133(2012).
  • Greenberg JD , KremerJM, CurtisJRet al. Tumor necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis. Ann. Rheum. Dis. 70(4), 576–582(2011).
  • Curtis JR , LanasA, JohnA, JohnsonDA, SchulmanKL. Factors associated with a risk of GI perforation in a cohort of patients with rheumatoid arthritis. Arthritis Care Res.64(12), 1819–1828(2012).
  • Innala L , MollerB, LjungLet al. Age at onset determines severity and choice of treatment in early rheumatoid arthritis. Arthritis Rheum. 64(S10), Abstract 2145 (2012).
  • Wolfe F , MichaudK. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum.58(9), 2612–2621(2008).
  • Suissa S , BernatskyS, HudsonM. Antirheumatic drug use and the risk of acute myocardial infarction. Arthritis Care Res.55(4), 531–536(2006).
  • Furst DE , KeystoneEC, BraunJet al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. Ann. Rheum. Dis. 71(Suppl. 2), i2–i45 (2012).
  • Curtis JR , XieF, ChenLet al. Use of a disease risk score to compare serious adverse infections associated with anti-tumor necrosis factor therapy among high- versus low-risk rheumatoid arthritis patients. Arthritis Care Res. 64(10), 1480–1489(2012).
  • Whittle SL , ColebatchAN, BuchbinderRet al. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology 51, 1416–1425(2012).
  • Fleischmann R , KremerJ, CushJet al. Placebo-controlled trial of Tofacitinib monotherapy in rheumatoid arthritis. N. Engl. J. Med. 367(6), 495–507(2012).
  • van Vollenhoven R , FleischmannR, CohenSet al. Tofacitinib or Adalimumab versus placebo in rheumatoid arthritis. N. Engl. J. Med. 367, 508–519(2012).
  • Buttgereit F , DoeringG, SchaefflerAet al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann. Rheum. Dis. 69, 1275–1280(2010).
  • Makol A , WrightK, MattesonEL. Safe uses of anti-rheumatic agents in patients with comorbidities. Rheum. Dis. Clinics North Am.38(4), 771–793(2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.